Explore 3 Stock Ideas & Industry Insights Download Free Report

AbbVie CDR (CAD Hedged)

None CA ABBV

32.11CAD
1.80(5.94%)

Last update at 2026-06-22T19:57:00Z

Day Range

32.0032.31
LowHigh

52 Week Range

24.5633.69
LowHigh

Fundamentals

  • Previous Close 30.31
  • Market Cap371900.00M
  • Volume9707
  • P/E Ratio84.53
  • Dividend Yield23.25%
  • Revenue TTM0.00000M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.00000M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown
Breakdown
Breakdown

Peer Comparison

Sector: None Industry: None

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ABBV
AbbVie CDR (CAD Hedged)
1.80 5.94% 32.11 84.53 13.62 5.74 50.90 6.95 24.11
AVGO
Broadcom CDR (CAD Hedged)
-0.71 4.51% 15.04 12.44 5.73 4.54 3.78 28.65 52.40
WMT
Walmart CDR (CAD Hedged)
0.11 0.22% 49.08 45.06 41.67 1.38 9.84 1.51 23.16
LLY
Eli Lilly CDR (CAD Hedged)
0.26 0.66% 39.62 37.91 25.77 12.03 29.35 12.92 26.57
JPM
JPMorgan CDR (CAD Hedged)
0.54 1.29% 42.50 14.46 14.03 4.49 2.36 6.97

Reports Covered

Stock Research & News

Key Executives

Name Title Year Born
Mr. Robert A. Michael CPA CEO & Chairman of the Board 1970
Mr. Scott T. Reents Executive VP & CFO 1967
Dr. Azita Saleki-Gerhardt Ph.D. Executive VP & COO 1963
Mr. Jeffrey Ryan Stewart Executive VP & Chief Commercial Officer 1969
Dr. Roopal Thakkar M.D. Executive VP of Research and Development & Chief Scientific Officer 1972
Ms. Elizabeth Shea Senior Vice President of Investor Relations NA
Mr. Perry C. Siatis Executive VP, General Counsel & Secretary 1975
Mr. Demetris D. Crum Executive VP & Chief Human Resources Officer NA
Mr. Wulff-Erik von Borcke Senior VP & President of Oncology NA
Dr. Nicholas J. Donoghoe M.D. Executive VP and Chief Business & Strategy Officer 1981

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.